Sharps Technology Warrant Stock Today
| STSSW Stock | USD 0.03 0 11.15% |
PerformanceOK
| Odds Of DistressDangerous
|
Sharps Technology is selling for under 0.0279 as of the 25th of February 2025; that is 11.15 percent down since the beginning of the trading day. The stock's lowest day price was 0.0211. Sharps Technology has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 27th of November 2024 and ending today, the 25th of February 2025. Click here to learn more.
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. The company was incorporated in 2017 and is based in Melville, New York. Sharps Technology operates under Capital Markets classification in the United States and is traded on NASDAQ Exchange. More on Sharps Technology Warrant
Moving against Sharps Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Sharps Stock Highlights
Sharps Technology Warrant (STSSW) is traded on NASDAQ Exchange in USA. It is located in 105 Maxess Road, Melville, NY, United States, 11747 and employs 57 people. Sharps Technology is listed under Asset Management & Custody Banks category by Fama And French industry classification. The company classifies itself under Capital Markets sector and is part of Financials industry.
Sharps Technology Warrant has accumulated about 1.48 M in cash with (8.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Sharps Technology Probability Of Bankruptcy
Sharps Technology Warrant Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Sharps Technology market risk premium is the additional return an investor will receive from holding Sharps Technology long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.0799 | |||
| Jensen Alpha | 1.78 | |||
| Total Risk Alpha | 1.66 | |||
| Sortino Ratio | 0.1014 |
Sharps Stock Against Markets
Sharps Technology Corporate Management
| Robert Hayes | CEO Director | Profile | |
| Alan Blackman | Chief CoChairman | Profile | |
| Steven MD | Chief Officer | Profile | |
| Ben Scheu | Senior Sales | Profile | |
| Frank Parrado | Corporate Controller | Profile | |
| Barry Berler | Chief Inventor | Profile |
Additional Tools for Sharps Stock Analysis
When running Sharps Technology's price analysis, check to measure Sharps Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sharps Technology is operating at the current time. Most of Sharps Technology's value examination focuses on studying past and present price action to predict the probability of Sharps Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sharps Technology's price. Additionally, you may evaluate how the addition of Sharps Technology to your portfolios can decrease your overall portfolio volatility.